ABOUT US
Nexsis Biosciences specializes in identifying unmet clinical needs, developing and delivering advanced biomaterial solutions based on our knowledge of naturally occurring extracellular matrices (ECM) and other novel biomaterials.
Every Successful Innovation has a Story.
This innovation story began more than 30 years ago, when a Purdue University biomedical engineering team discovered the regenerative properties of porcine small intestinal submucosa (SIS) and other extracellular matrix materials.
Dr. Leslie Geddes at Purdue University discovered the unique regenerative capabilities of SIS over 30 years ago. Since then, this technology has been used by hospitals around the world.1
In 1995, based on research supporting the versatility and effectiveness of SIS, Cook Group Incorporated licensed the technology from the Purdue Research Foundation and established Cook Biotech Incorporated to develop and commercialize the new biomaterials. This collaboration bridged the two worlds of a well-established, innovative medical company and a prestigious research university.
Since then, Cook Biotech has developed and manufactured products for clinical applications ranging from dura repair to diabetic foot ulcers, from dental repair to hernia repair. To date, Cook Biotech has shipped more than 6 million products through their global network of partners and distributors. In 2024, Cook Biotech was acquired by Evergen, a world-class Contract Development and Manufacturing Organization.
Nexsis Biosciences is committed to meeting the needs of healthcare providers and their patients, by developing and delivering novel biomaterials and solutions to address current as well as unmet clinical needs.
REFERENCES
Images sourced from cookbiotech.com unless otherwise noted.
1. www.purdue.edu/uns/html3month/2006/060922CelebrationGeddes.html